Guidance

V3P: PCV Fact sheet

This product fact sheet is intended for use by global and regional vaccine policy makers. The product fact sheet provides information on PCV procured by V3P reporting countries, including analyses of:

• value to the market of PCV reported globally and in each WHO region;

• the distribution of available presentations globally and in each WHO region;

• the procurement methods used globally and in each WHO region;

• prices paid globally and in each WHO region, by income segment.

The Vaccine Product Price & Procurement (V3P) initiative was launched to provide all countries with a platform for greater vaccine price & procurement transparency. The initiative collects data through the WHO and UNICEF Joint Reporting Form, analyses and distributes information to relevant stakeholders to inform policy making and procurement processes. As of July 2017, the database contained data from 144 countries.

Languages

  • English

Publication year

2018

Publisher

WHO

Type

Guidance

Categories

  • Programme management

Organisations

  • WHO

Tags

  • Facility-based records
  • MI4A

Topic references

MARKET_STUDIES

TitleAuthorYearTypeLanguage
Global Market Study: BCG Vaccine - May 2019World Health Organization (WHO)2019ReportEnglish
Global Market Study: Diphtheria and tetanus-containing vaccines - 2019World Health Organization (WHO)2019ReportEnglish
Global Market Study: Hepatitis A virus - 2023World Health Organization (WHO)2023ReportEnglish
Global Market Study: HPV - 2019World Health Organization (WHO)2019ReportEnglish
Global Market Study: Meningococcal meningitis vaccines - 2019World Health Organization (WHO)2019ReportEnglish
Global Vaccine Market Report - 2018World Health Organization (WHO)2018ReportEnglish
Global Vaccine Market Report - 2019World Health Organization (WHO)2019ReportEnglish
V3P: Key Findings for RotaWorld Health Organization (WHO)2018GuidanceEnglish
V3P: PCV Fact sheetWorld Health Organization (WHO)2018GuidanceEnglish